Zobrazeno 1 - 10
of 227
pro vyhledávání: '"Eiichiro KANDA"'
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-13 (2024)
Abstract Background In Japan dialyzers are classified as type I, II, III, IV, or V on the basis of the β 2-microglobulin clearance. In 2023, Type V dialyzers were defined as super high-flux membrane dialyzers. Herein, we investigate the association
Externí odkaz:
https://doaj.org/article/3f7590f19127499a99f9e232ac2e793b
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Dialyzers are classified into five types based on their β2-microglobulin clearance rate and albumin sieving coefficient: Ia, Ib, IIa, and IIb. In addition, a new classification system introduced a type S dialyzer. However, limited informati
Externí odkaz:
https://doaj.org/article/55283026b8d947c98271beff4d3e24c5
Autor:
Kayo Waki, Mitsuhiko Nara, Syunpei Enomoto, Makiko Mieno, Eiichiro Kanda, Akiko Sankoda, Yuki Kawai, Kana Miyake, Hiromichi Wakui, Yuya Tsurutani, Nobuhito Hirawa, Tadashi Yamakawa, Shiro Komiya, Akihiro Isogawa, Shinobu Satoh, Taichi Minami, Tamio Iwamoto, Tatsuro Takano, Yasuo Terauchi, Kouichi Tamura, Toshimasa Yamauchi, Masaomi Nangaku, Naoki Kashihara, Kazuhiko Ohe
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-12 (2024)
Abstract We evaluated the effectiveness of a mobile health (mHealth) intervention for diabetic kidney disease patients by conducting a 12-month randomized controlled trial among 126 type 2 diabetes mellitus patients with moderately increased albuminu
Externí odkaz:
https://doaj.org/article/84d1a649ca5c4b8488247a76bd255375
Autor:
Norio Hanafusa, Masanori Abe, Nobuhiko Joki, Junichi Hoshino, Kan Kikuchi, Shunsuke Goto, Eiichiro Kanda, Masatomo Taniguchi, Shigeru Nakai, Toshihide Naganuma, Takeshi Hasegawa, Kenichiro Miura, Atsushi Wada, Yoshiaki Takemoto, Japanese Society for Dialysis Therapy Renal Data Registry Committee
Publikováno v:
Renal Replacement Therapy, Vol 10, Iss 1, Pp 1-31 (2024)
Abstract Background The 2020 Japanese Society for Dialysis Therapy Renal Data Registry (JRDR) annual survey was sent to 4493 dialysis facilities in Japan. Methods Questionnaires were sent to all facilities that provide patients with dialysis therapy
Externí odkaz:
https://doaj.org/article/df926920438f4a109b58c7b52eaa90bb
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract A new marker reflecting the pathophysiology of chronic kidney disease (CKD) has been desired for its therapy. In this study, we developed a virtual space where data in medical words and those of actual CKD patients were unified by natural la
Externí odkaz:
https://doaj.org/article/741e64214a9346a686127f9d5a2925b7
Autor:
Norio Hanafusa, Masanori Abe, Nobuhiko Joki, Tetsuya Ogawa, Eiichiro Kanda, Kan Kikuchi, Shunsuke Goto, Masatomo Taniguchi, Shigeru Nakai, Toshihide Naganuma, Takeshi Hasegawa, Junichi Hoshino, Kenichiro Miura, Atsushi Wada, Yoshiaki Takemoto, on behalf of Japanese Society for Dialysis Therapy Renal Data Registry Committee
Publikováno v:
Renal Replacement Therapy, Vol 9, Iss 1, Pp 1-37 (2023)
Abstract Background The Japanese Society for Dialysis Therapy is conducting the survey annually since 1968. The results provide a comprehensive picture of dialysis therapy in Japan. The survey for the year 2019 was performed as of December 2019. Meth
Externí odkaz:
https://doaj.org/article/19491d8f76d142e39e093641d0bbc10d
Autor:
Kayo Waki, Mitsuhiko Nara, Syunpei Enomoto, Makiko Mieno, Eiichiro Kanda, Akiko Sankoda, Yuki Kawai, Kana Miyake, Hiromichi Wakui, Yuya Tsurutani, Nobuhito Hirawa, Tadashi Yamakawa, Shiro Komiya, Akihiro Isogawa, Shinobu Satoh, Taichi Minami, Tamio Iwamoto, Tatsuro Takano, Yasuo Terauchi, Kouichi Tamura, Toshimasa Yamauchi, Masaomi Nangaku, Naoki Kashihara, Kazuhiko Ohe
Publikováno v:
npj Digital Medicine, Vol 7, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/d29a050f7e644f7a8609df9407440215
Autor:
Hajime Nagasu, Atsuyuki Tokuyama, Eiichiro Kanda, Seiji Itano, Seiji Kishi, Tamaki Sasaki, Naoki Kashihara
Publikováno v:
Kidney and Dialysis, Vol 3, Iss 3, Pp 244-254 (2023)
Hyperkalemia is associated with an increased risk of mortality and is a common complication in patients with chronic kidney disease (CKD). Despite the prevalence of hyperkalemia, current real-world data suggest that serum potassium levels are not eff
Externí odkaz:
https://doaj.org/article/a8c40f13ca684a76b85fdd57308f5a81
Autor:
Yuki Nishida, Yosuke Yamada, Satoshi Sasaki, Eiichiro Kanda, Yoshihiko Kanno, Tatsuhiko Anzai, Kunihiko Takahashi, Keita Yamauchi, Fuminori Katsukawa
Publikováno v:
Obesity Science & Practice, Vol 10, Iss 1, Pp n/a-n/a (2024)
Abstract Background The potential for developing frailty exists in middle‐aged and older adults. While obesity and metabolic syndrome (MetS) increase the risk of frailty in older adults, this relationship remains unclear in middle‐aged adults, wh
Externí odkaz:
https://doaj.org/article/39cbbb5662484d84aeff6d973ad413ed
Autor:
Kanako Sakaeda, Koji Kurose, Yuki Matsumura, Satoshi Muto, Minoru Fukuda, Nanae Sugasaki, Masaaki Fukuda, Shinnosuke Takemoto, Hirokazu Taniguchi, Takeshi Masuda, Katsuhiko Shimizu, Yuki Kataoka, Yasuhiro Irino, Yumiko Sakai, Yusuke Atarashi, Masatoshi Yanagida, Noboru Hattori, Hiroshi Mukae, Masao Nakata, Eiichiro Kanda, Toru Oga, Hiroyuki Suzuki, Mikio Oka
Publikováno v:
Cancer Treatment and Research Communications, Vol 40, Iss , Pp 100830- (2024)
Background: NY-ESO-1 and XAGE1 cancer/testis antigens elicit humoral and cellular immune responses in NSCLC patients. We aimed to predict clinical benefit with ICI monotherapy, using an automated immunoassay of NY-ESO-1/XAGE1 antibodies (Abs). Method
Externí odkaz:
https://doaj.org/article/fa49acdde51b426e87156baacb0661b1